3rd Quarter - Report — MARS, INCORPORATED for MARS, INCORPORATED (2021)

Firm

MARS, INCORPORATED

Client

MARS, INCORPORATED

Income

—

Expenses

$390,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Government Issues GOV

HR 4350, proposals related to government contracting.

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—
PETER ROWAN	—

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4350 (117th)

Science/Technology SCI

Advocacy related to data privacy legislation.

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Immigration IMM

Support for S 264, the DREAM Act (entire bill)

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—
PETER ROWAN	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Agriculture AGR

Support for policies to incentivize agriculture producers to reduce greenhouse gas emissions, such as S. 1251, The Growing Climate Solutions Act.

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—
RACHEL GOLDSTEIN New	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA)

Bills named: S. 1251 (117th)

Taxation/Internal Revenue Code TAX

Corporate income tax rate policies in HR 5376, including proposed limits on domestic corporations. Recognition of US global tax regime in international tax negotiations.

Lobbyist	Covered position, as disclosed
PETER ROWAN	—

Contacted: U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Issues related to energy savings and climate change, including US support for the Paris Climate Agreement, support for carbon pricing, support for clean energy deployment and resilient infrastructure.

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—
RACHEL GOLDSTEIN	—
PETER ROWAN	—

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Trade (domestic/foreign) TRD

Support for extension of Generalized System of Preferences reauthorization and reinstatement of India to the program; support for Miscellaneous Tariff Bill; support for mandatory corporate due diligence reporting on supply chain issues; funding for international aid and development programs, including ILAB and USAID; support for legislation to combat deforestation in global supply chains.

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—
PETER ROWAN	—

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Civil Rights/Civil Liberties CIV

Support for S393, the Equality Act (entire bill); support for HR 959, the Black Maternal Health Omnibus Act (entire bill); support for voting rights legislation.

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—
RACHEL GOLDSTEIN New	—

Contacted: SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 959 (117th)

Food Industry (safety, labeling, etc.) FOO

Supporting FDA voluntary guidance on sodium and sodium reduction in the Child Nutrition Program, Preventative oral health, food ingredient policy, and dietary guidelines; funding for Food Safety Modernization Act; funding for pet food ingredient reviews; support for policies that improve the US recycling infrastructure, including support for EPR fees; inquiries to understand policy proposals to improve the nations recycling infrastructure, such as the Break Free from Plastics Pollution Act of 2021.

Lobbyist	Covered position, as disclosed
BRAD G FIGEL	—
RACHEL GOLDSTEIN	—
PETER ROWAN	—

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.